Healthcare provider profile · identity verified

Kevin Christopher Mcmahon, M.D.

Family Practice · EAST AURORA, NY · NPI 1528032695

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	661	166
Amlodipine Besylate	Amlodipine Besylate	553	140
Levothyroxine Sodium	Levothyroxine Sodium	508	114
Atorvastatin Calcium	Atorvastatin Calcium	505	126
Metoprolol Succinate	Metoprolol Succinate	453	111
Lisinopril	Lisinopril	448	114
Famotidine	Famotidine	281	63
Omeprazole	Omeprazole	205	48
Metformin Hcl	Metformin Hcl	194	44
Furosemide	Furosemide	189	45
Pantoprazole Sodium	Pantoprazole Sodium	189	52
Irbesartan	Irbesartan	173	41
Eliquis	Apixaban	163	28
Losartan Potassium	Losartan Potassium	162	43
Hydrochlorothiazide	Hydrochlorothiazide	140	37
Albuterol Sulfate Hfa	Albuterol Sulfate	135	50
Ezetimibe	Ezetimibe	124	26
Escitalopram Oxalate	Escitalopram Oxalate	117	26
Gabapentin	Gabapentin	109	22
Jardiance	Empagliflozin	106	18
Meloxicam	Meloxicam	103	26
Pravastatin Sodium	Pravastatin Sodium	103	26
Fluticasone Propionate	Fluticasone Propionate	102	36
Fluoxetine Hcl	Fluoxetine Hcl	100	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	98	28
Simvastatin	Simvastatin	91	25
Tamsulosin Hcl	Tamsulosin Hcl	91	19
Prednisone	Prednisone	90	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	20
Venlafaxine Hcl Er	Venlafaxine Hcl	86	17
Glipizide Er	Glipizide	85	18
Clopidogrel	Clopidogrel Bisulfate	83	19
Trazodone Hcl	Trazodone Hcl	80	21
Allopurinol	Allopurinol	70	18
Citalopram Hbr	Citalopram Hydrobromide	69	15
Atenolol	Atenolol	66	17
Synthroid	Levothyroxine Sodium	66	18
Azelastine Hcl	Azelastine Hcl	63	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	12
Zolpidem Tartrate	Zolpidem Tartrate	59	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	51
Celecoxib	Celecoxib	57	16
Metoprolol Tartrate	Metoprolol Tartrate	56	14
Warfarin Sodium	Warfarin Sodium	53	suppressed
Montelukast Sodium	Montelukast Sodium	47	13
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Clonidine Hcl	Clonidine Hcl	45	suppressed
Lorazepam	Lorazepam	45	19
Verapamil Sr	Verapamil Hcl	45	suppressed
Azithromycin	Azithromycin	44	41
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	11
Potassium Chloride	Potassium Chloride	43	14
Pregabalin	Pregabalin	42	suppressed
Sertraline Hcl	Sertraline Hcl	42	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	suppressed
Methylprednisolone	Methylprednisolone	41	39
Tramadol Hcl	Tramadol Hcl	41	suppressed
Lovastatin	Lovastatin	39	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Alprazolam	Alprazolam	36	13
Xarelto	Rivaroxaban	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Glipizide	Glipizide	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	12
Bupropion Xl	Bupropion Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	17
Valsartan	Valsartan	30	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	11
Amoxicillin	Amoxicillin	26	16
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Ketoconazole	Ketoconazole	22	17
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Nitroglycerin	Nitroglycerin	18	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Cephalexin	Cephalexin	14	12
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	13	13
Aripiprazole	Aripiprazole	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Telmisartan	Telmisartan	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Finasteride	Finasteride	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Paxil Cr	Paroxetine Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Epinephrine	Epinephrine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error